Oak Ridge Investments LLC Halozyme Therapeutics, Inc. Transaction History

Oak Ridge Investments LLC

$1.25 Billion
Q4 2024

A detailed history of Oak Ridge Investments LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Oak Ridge Investments LLC holds 58,220 shares of HALO stock, worth $3.25 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

58,220

Previous 60,340 3.51%

Holding current value

$3.25 Million

Previous $3.45 Million 19.38%

% of portfolio

0.22%

Previous 0.3%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$42.57 - $61.09 $90,248 - $129,510	-2,120 Reduced 3.51%	58,220 $2.78 Million
Q3 2024 Oct 28, 2024	SELL	$51.3 - $64.42 $124,812 - $156,733	-2,433 Reduced 3.88%	60,340 $3.45 Million
Q2 2024 Jul 16, 2024	SELL	$37.81 - $52.4 $345,961 - $479,460	-9,150 Reduced 12.72%	62,773 $3.29 Million
Q1 2024 May 01, 2024	SELL	$33.68 - $41.95 $126,300 - $157,312	-3,750 Reduced 4.96%	71,923 $2.93 Million
Q4 2023 Jan 16, 2024	SELL	$33.32 - $42.1 $202,718 - $256,136	-6,084 Reduced 7.44%	75,673 $2.8 Million
Q3 2023 Oct 30, 2023	SELL	$36.46 - $44.03 $102,853 - $124,208	-2,821 Reduced 3.34%	81,757 $3.12 Million
Q2 2023 Aug 07, 2023	SELL	$30.28 - $38.74 $86,388 - $110,525	-2,853 Reduced 3.26%	84,578 $3.05 Million
Q1 2023 Apr 14, 2023	SELL	$32.86 - $55.7 $185,166 - $313,869	-5,635 Reduced 6.05%	87,431 $3.34 Million
Q4 2022 Jan 24, 2023	SELL	$40.06 - $59.44 $82,323 - $122,149	-2,055 Reduced 2.16%	93,066 $0
Q3 2022 Nov 08, 2022	SELL	$38.53 - $51.78 $31,671 - $42,563	-822 Reduced 0.86%	95,121 $3.76 Million
Q2 2022 Jul 28, 2022	SELL	$37.35 - $48.3 $197,469 - $255,362	-5,287 Reduced 5.22%	95,943 $4.22 Million
Q1 2022 Apr 22, 2022	SELL	$31.97 - $41.06 $1.85 Million - $2.38 Million	-57,921 Reduced 36.39%	101,230 $4.04 Million
Q4 2021 Feb 01, 2022	SELL	$31.82 - $40.75 $85,532 - $109,536	-2,688 Reduced 1.66%	159,151 $6.4 Million
Q3 2021 Nov 05, 2021	SELL	$38.47 - $46.42 $181,847 - $219,427	-4,727 Reduced 2.84%	161,839 $6.58 Million
Q2 2021 Jul 30, 2021	SELL	$38.84 - $51.31 $468,255 - $618,593	-12,056 Reduced 6.75%	166,566 $7.56 Million
Q1 2021 May 12, 2021	SELL	$39.51 - $51.45 $50.2 Million - $65.3 Million	-1,269,991 Reduced 87.67%	178,622 $7.45 Million
Q1 2021 May 04, 2021	SELL	$39.51 - $51.45 $7.21 Million - $9.39 Million	-182,537 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$25.81 - $43.62 $1.1 Million - $1.85 Million	-42,482 Reduced 18.88%	182,537 $7.8 Million
Q3 2020 Nov 12, 2020	BUY	$25.74 - $29.63 $5.79 Million - $6.67 Million	225,019 New	225,019 $5.91 Million

Others Institutions Holding HALO

# of Institutions

539

Shares Held

126M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.77B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.

Account

Oak Ridge Investments LLC Halozyme Therapeutics, Inc. Transaction History